Methotrexate, Once Weekly - Said Out Loud at the Counter
A 68-year-old woman with rheumatoid arthritis brings in a new prescription: methotrexate 2.5 mg tablets, quantity 16, "take four tablets (10 mg) by mouth once weekly." She also takes folic acid 1 mg daily, lisinopril, and ibuprofen as needed. The technician has already rung up the prescription and is holding the bag out when the patient says cheerfully, "I'm so glad this is a pill now - the shots were such a hassle. I'll take mine every morning with my water pill, like I do the folic acid." The label is printed correctly. Six patients are in line, a car has been idling in the drive-through for four minutes, and the technician says, "The label's right there, she'll be fine." The pharmacist has not yet spoken with the patient.
1. What must happen before the bag leaves the counter, and who must do it?
Read the worked answer
The bag does not leave the counter until a pharmacist has spoken with her. This is not optional, and it is not a task a technician can complete.
- The pharmacist must intervene personally. Counseling is part of the practice of pharmacy and cannot be delegated to a registered technician. A technician may hand over a prescription only after the pharmacist has completed the counseling or the patient has declined it.
- The error is not in the label - it is in the patient's understanding. The prescription is technically perfect. The hazard is that she intends to take a weekly antimetabolite every day. Daily methotrexate causes severe bone-marrow suppression, mucosal ulceration, hepatic and pulmonary injury, and death; it is one of the classic fatal pharmacy errors. A correct label that the patient misreads is still a dispensing error waiting to happen.
- Verify the prescriber's intent is weekly while the patient is at the counter (it will be - weekly is standard for rheumatoid arthritis), and check the quantity: 16 tablets equals four weekly doses, which is consistent.
- Counseling cannot be declined away here. If she refuses counseling, the pharmacist must still correct the misunderstanding out loud, because the pharmacist now has actual knowledge of an imminent risk. Then document the refusal.
2. What must the counseling cover, and how should the pharmacist confirm the patient actually understands?
Read the worked answer
Content:
- One dose, one day, once a week. Name the specific day and write it down. Distinguish it explicitly from the folic acid she takes every day - the pairing of a daily and a weekly tablet in the same regimen is the setup for this error.
- What to do if a dose is missed - call the prescriber; do not double up the next day.
- Alcohol avoidance, and that the ibuprofen she uses as needed should be discussed with the prescriber because of additive toxicity.
- Warning signs to report: mouth sores, fever, unusual bruising or bleeding, shortness of breath or new cough, jaundice, blood in the stool or vomit.
- Pregnancy and pregnancy prevention - she is 68, but the question should still be asked, since the drug is teratogenic and the answer changes the counseling.
- Written reinforcement: a weekly dosing calendar and an auxiliary "ONCE WEEKLY" label, not just the pharmacy label.
Confirmation: use teach-back. Not "Do you have any questions?" - ask her to say back how many tablets she will take and on which days. If she says "four every morning," the counseling has not succeeded and must be repeated with a different explanation. Ask her to demonstrate which bottle she would open tomorrow morning. Document the teach-back outcome, because "patient counseled" in a system field tells a reviewer nothing about whether understanding occurred.
3. What follow-up and system-level actions should the pharmacist take after the patient leaves, and how should the file read?
Read the worked answer
Patient-level follow-up:
- A follow-up phone call in a few days to confirm she is taking it weekly and has not taken a daily dose - this is the interval in which a misunderstanding becomes an injury.
- Document the intervention: what she said, what was corrected, who counseled, whether teach-back succeeded, what written materials were provided, and any prescriber contact.
System-level fixes (this error class recurs because of how the product is stored and labeled, not because one technician was careless):
- Apply a distinctive "WEEKLY - NOT DAILY" auxiliary label at every fill, and consider a separate high-visibility warning affixed at the printer.
- Store methotrexate apart from daily anti-inflammatory and folic-acid stock, and flag it in the pharmacy system with a hard-stop prompt at verification.
- Separate methotrexate from look-alike products (folic acid, leucovorin, and similar tablets) on the shelf.
- Build a required pharmacist-counseling prompt for methotrexate that cannot be bypassed by the technician at the register.
- Share the near miss in the pharmacy's quality program so it becomes a system correction rather than a story about one patient.
The file should read as a record of a near miss that was caught at the counter by a pharmacist doing exactly the job the law reserves to pharmacists - not as a routine dispensing with a checked counseling box.